
Avalo Therapeutics
Avalo Therapeutics is a clinical stage biotechnology company focused on the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network.
Market cap
$123m
Enterprise value
$10m
Share price
$9.34 AVTX
Authorizing premium user...